Vaginal Estrogen for Asymptomatic Microscopic Hematuria

Description

The specific aim of this protocol is to determine whether vaginal estrogen is an effective treatment for asymptomatic microscopic hematuria in postmenopausal women. The investigators hypothesize that women who use vaginal estrogen for three months will be more likely to have resolution of their asymptomatic microscopic hematuria compared with women who do not use vaginal estrogen.

Study Start Date

December, 01 2016

Estimated Completion Date

December 2020

Interventions

  • Drug: Estradiol Ring

Study ID

Boston Urogynecology Associates -- 052-2015

Status

Recruiting

Trial ID

NCT03033160

Study Type

Interventional

Trial Phase

Phase 4

Enrollment Quota

68

Sponsor

Boston Urogynecology Associates

Inclusion Criteria

  • Postmenopausal, defined by amenorrhea for at least one year or a bilateral oophorectomy at least one year prior, and have three or more red blood cells per high powered field visible in a properly collected urine specimen without evidence of infection. In addition, women must have a negative cystoscopy and computed tomography urogram (or magnetic resonance urography if history of renal insufficiency or contrast allergy) within the past three years.

Exclusion Criteria

  • Current or past thromboembolic disorder or cerebrovascular accident
  • Intolerance to previous estrogen replacement therapy or hormone replacement therapy
  • Estrogen dependent neoplasm within the past five years (unless supporting documentation from patient's oncologist is obtained)
  • Estrogen replacement therapy or hormone replacement therapy within the past three months or selective estrogen receptor modulators within eight weeks of enrollment
  • Urinary tract infection
  • Urinary calculi
  • Urinary tract malignancy
  • Vaginal bleeding of unknown origin
  • Urethral caruncle
  • History of recurrent urinary tract infections in the last one year
  • Stage two or greater pelvic organ prolapse.

Gender

Female

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Mount Auburn Hospital - Cambridge, Massachusetts 2.6 miles Kathleen Rogers 617-354-5452 krogers2@mah.harvard.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.